Senior insider sale
Chief Business Officer at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$1.71M
21.92K shares
What this filing means
BAROLDI JOSEPH plans to sell 21.92K shares of IONIS PHARMACEUTICALS INC valued at approximately $1.71M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/16/2026ACC: 0000874015-26-000162
Officer· Chief Business Officer
Since Jan 2022
21.92K
Shares to sell
$1.71M
Approx. market value
5.62K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
RSUs granted under 2011 Equity Incentive Plan
Compensation
4/16/2026
5.62KTotal acquired5.62K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/16/2026 | RSUs granted under 2011 Equity Incentive Plan Compensation | 5.62K | — |
| Total | 5.62K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.10K
Market value
$325.1K
3/3/2026
—Completed
Units to sell
5.30K
Market value
$439.7K
1/30/2026
—Completed
Units to sell
6.91K
Market value
$523.2K
1/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.62K
Market value
$423.7K
4/16/2026
Total
Units
21.92K
Value
$1.71M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2026 | 4.10K | $325.1K | — | Completed |
1/30/2026 | 5.30K | $439.7K | — | Completed |
1/16/2026 | 6.91K | $523.2K | — | Completed |
| Planned — Approximate Date | ||||
4/16/2026 | 5.62K | $423.7K | NASDAQ | Planned |
| Total | 21.92K | $1.71M | ||